Recent surveys have shown that pharmaceutical companies and the industry in general is challenged with over 50% failures of new drug launches.

RWD offers meaningful insight into diverse populations, the amount of data collection would be voluminous in a short span of time. The RWD collected in a post marketing stage can augment the value to the CT Data.